Cite
Westhrin M, Holien T, Zahoor M, et al. Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone. JBMR Plus. 2019;4(1):e10247doi: 10.1002/jbm4.10247.
Westhrin, M., Holien, T., Zahoor, M., Moen, S. H., Buene, G., Størdal, B., Hella, H., Yuan, H., de Bruijn, J. D., Martens, A., Groen, R. W., Bosch, F., Smith, U., Sponaas, A. M., Sundan, A., & Standal, T. (2020). Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone. JBMR plus, 4(1), e10247. https://doi.org/10.1002/jbm4.10247
Westhrin, Marita, et al. "Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone." JBMR plus vol. 4,1 (2020): e10247. doi: https://doi.org/10.1002/jbm4.10247
Westhrin M, Holien T, Zahoor M, Moen SH, Buene G, Størdal B, Hella H, Yuan H, de Bruijn JD, Martens A, Groen RW, Bosch F, Smith U, Sponaas AM, Sundan A, Standal T. Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone. JBMR Plus. 2019 Nov 22;4(1):e10247. doi: 10.1002/jbm4.10247. eCollection 2020 Jan. PMID: 31956851; PMCID: PMC6957984.
Copy
Download .nbib